Reciprocal transactivation between HIV-1 and other human viruses (Q36489392)

14 August 2017

1 reference

title

Reciprocal transactivation between HIV-1 and other human viruses (English)

1 reference

14 August 2017

0 references

Martyn K White

1 reference

14 August 2017

Timothy S Gorrill

series ordinal

1 reference

14 August 2017

Kamel Khalili

series ordinal

1 reference

14 August 2017

language of work or name

English

0 references

publication date

24 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

352

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

1-13

1 reference

Tuberculosis in HIV-infected patients: a comprehensive review.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Angiogenic properties of human immunodeficiency virus type 1 Tat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Epstein-Barr virus associated lymphoproliferations in the AIDS setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Effect of HIV-1 Vpr on cell cycle regulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cytomegalovirus polyradiculopathy in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cytomegalovirus colitis in AIDS: radiographic findings in 11 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HTLV-I and HTLV-II virus expression increase with HIV-1 coinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Progressive Multifocal Leukoencephalopathy in Acquired Immunodeficiency Syndrome: Explaining the High Incidence and Disproportionate Frequency of the Illness Relative to Other Immunosuppressive Conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Biology of Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV Type 1 Tat Protein Is a Survival Factor for Kaposi's Sarcoma and Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

A practitioner's guide to human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cyclin encoded by KS herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

TNF-R1 signaling: a beautiful pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Therapies. Raising the limits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

IL-10 production induced by HIV-1 Tat stimulation of human monocytes is dependent on the activation of PKC beta(II) and delta isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

BK virus infection in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV disorders of the brain: pathology and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Leishmania/HIV co-infections: epidemiology in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human herpesvirus 6: molecular biology and clinical features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Biology of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cellular uptake of the tat protein from human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-1: fifteen proteins and an RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The enigmas of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV receptors on lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Enhancement of TAT-induced transactivation of the HIV-1 LTR by two genomic fragments of HHV-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Kaposi's sarcoma in Italy before and after the AIDS epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The HIV-1 Tat protein: a multifaceted target for novel therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Chemokine regulation of inflammation during acute viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Viral lesions of the mouth in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Purified Tat induces inflammatory response genes in Kaposiʼs sarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Etiology and pathogenesis of AIDS-related non--Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Active HHV-6 infection in the lymph nodes of HIV-infected patients: in vitro evidence that HHV-6 can break HIV latency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human herpesvirus 6 in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Interactions between HIV-1 and cytomegalovirus in human osteosarcoma cells carrying both viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Kaposi's Sarcoma Cells of Different Etiologic Origins Respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): Relevance in AIDS-KS Pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Viral exploitation and subversion of the immune system through chemokine mimicry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Current views in HTLV-I-associated adult T-cell leukemia/lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

AIDS-associated cancer in developing nations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The multiple functions of HIV-1 Tat: proliferation versus apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Reciprocal regulation of the nuclear factor of activated T cells and HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Detection and Sequence Analysis of Human Polyomaviruses DNA from Autoptic Samples of HIV-1 Positive and Negative Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Chromatin remodeling and modification during HIV-1 Tat-activated transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV-1 Tat induces cytokine synthesis by uninfected mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Chemokine induction by HIV-1: recruitment to the cause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV infection and neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Role of viral regulatory and accessory proteins in HIV-1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Biochemical mechanisms of HIV induced T cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Modulation of macrophage inflammatory protein-1alpha and its receptors in human B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The Human Immunodeficiency Virus tat Gene Enhances Replication of Human Herpesvirus-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The Human Herpes Virus 8-Encoded Viral FLICE-inhibitory Protein Induces Cellular Transformation via NF-κB Activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Interplay between NFBP and NF-kappaB modulates tat activation of the LTR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Induction of cell-cycle arrest in cervical cancer cells by the human immunodeficiency virus type 1 viral protein R.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

BK virus-associated haemorrhagic cystitis in an HIV-infected man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

HIV update 2005: origins, issues, prospects, and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

A recombinant HIV provirus is synergistically activated by the HIV Tat protein and the HSV IE1 protein but not by the HSV IE3 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Kaposi's sarcoma in organ transplant recipients: report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

Human herpesvirus type 8 and Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.006

7 January 2021

10.1016/J.VIROL.2006.04.006

Identifiers

DOI

1 reference

14 August 2017

1 reference